insights_auto
Why is BSLN up 3.05%?
Dive Deeperchevron_right
BSLN:SWX
Basilea Pharmaceutica AG Allschwil
CHF 67.60
arrow_upward
+3.05%(+2.00) 1D
Oct 19, 5:31:13 PM GMT+2 · CHF
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BSLN...
Open
CHF 65.60
High
CHF 67.60
Low
CHF 65.50
Mkt. cap
908.72M
Avg. vol.
32.28K
Volume
28.97K
P/E ratio
17.65
52-wk high
CHF 70.50
52-wk low
CHF 44.70
EPS
CHF 3.83
Shares outstanding
13.44M
No. of employees
200
Open
CHF 65.60
High
CHF 67.60
Low
CHF 65.50
Mkt. cap
908.72M
Avg. vol.
32.28K
Volume
28.97K
P/E ratio
17.65
52-wk high
CHF 70.50
52-wk low
CHF 44.70
EPS
CHF 3.83
Shares outstanding
13.44M
No. of employees
200
News stories
From web sources and news partners
Trefis
·
38 minutes ago
S&P 500 Movers | Winners: WDC, SNDK, DDOG | Losers: MOS, NRG, AMP
Stocktwits
·
1 hour ago
Dow, S&P 500, Nasdaq Edge Higher Amid Tech Rebound As Q3 Earnings Season Forges Ahead: DJT, AMZN, CBRS, CRWV Stocks In Focus
Yahoo Finance
·
19 hours ago
Is Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS) a Strong ETF Right Now?
Investing.com
·
8 hours ago
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.07%
Profile
Basilea Pharmaceutica is a biopharmaceutical company based in Allschwil near Basel, Switzerland. Basilea was spun off from F. Hoffmann-La Roche in 2000 and has been listed as an independent company on the Swiss stock exchange since March 2004. The company's subsidiary is Basilea Pharmaceutica International AG, Allschwil, which is also based in Allschwil, Switzerland, and in which the company's operating activities are bundled. Wikipedia
About Basilea Pharmaceutica AG Allschwil